Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer

Shiyong Xin^#^{1

2}, Xiang Liu^#^{1

3}, Ziyao Li¹, Xianchao Sun¹, Rong Wang⁴, Zhenhua Zhang⁵, Xinwei Feng⁶, Liang Jin¹, Weiyi Li¹, Chaozhi Tang¹, Wangli Mei¹, Qiong Cao⁷, Haojie Wang⁸, Jianguo Zhang², Lijin Feng⁹, Lin Ye¹⁰

Affiliations

¹ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, No.150, Ji-mo Rd, Pu-Dong New District, Shanghai, 200120, China.
² Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
³ Department of Urology, Putuo People's Hospital, School of Medicine, Shanghai, China.
⁴ School of Pharmacy, Inner Mongolia Medical University, Hohhot, 010000, China.
⁵ School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
⁶ School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, China.
⁷ Department of Pathology, The Third Affiliated Hospital of Henan University of Science and Technology, Henan, 471003, China.
⁸ Department of Central Laboratory, Zhengzhou University, Luoyang Central Hospital, Luoyang, 471003, China.
⁹ Department of Pathology, Jing'an District Zhabei Central Hospital, No.619, Zhonghuaxin Road, Shanghai, 200070, China. fenglijin_2049@tongji.edu.cn.
¹⁰ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, No.150, Ji-mo Rd, Pu-Dong New District, Shanghai, 200120, China. doctyelin@126.com.

^# Contributed equally.

Published Erratum

Shiyong Xin et al. Exp Hematol Oncol. 2024.

. 2024 May 20;13(1):54.

doi: 10.1186/s40164-024-00517-3.

¹ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, No.150, Ji-mo Rd, Pu-Dong New District, Shanghai, 200120, China.
² Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
³ Department of Urology, Putuo People's Hospital, School of Medicine, Shanghai, China.
⁴ School of Pharmacy, Inner Mongolia Medical University, Hohhot, 010000, China.
⁵ School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
⁶ School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, China.
⁷ Department of Pathology, The Third Affiliated Hospital of Henan University of Science and Technology, Henan, 471003, China.
⁸ Department of Central Laboratory, Zhengzhou University, Luoyang Central Hospital, Luoyang, 471003, China.
⁹ Department of Pathology, Jing'an District Zhabei Central Hospital, No.619, Zhonghuaxin Road, Shanghai, 200070, China. fenglijin_2049@tongji.edu.cn.
¹⁰ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, No.150, Ji-mo Rd, Pu-Dong New District, Shanghai, 200120, China. doctyelin@126.com.

^# Contributed equally.

No abstract available

Figures

ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.
Xin S, Liu X, Li Z, Sun X, Wang R, Zhang Z, Feng X, Jin L, Li W, Tang C, Mei W, Cao Q, Wang H, Zhang J, Feng L, Ye L. Xin S, et al. Exp Hematol Oncol. 2023 May 23;12(1):49. doi: 10.1186/s40164-023-00407-0. Exp Hematol Oncol. 2023. PMID: 37221625 Free PMC article.

1. Xin S, Liu X, Li Z, Sun X, Wang R, Zhang Z, Feng X, Jin L, Li W, Tang C, Mei W, Cao Q, Wang H, Zhang J, Feng L, Ye L. ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer. Exp Hematol Oncol. 2023;12:49. doi: 10.1186/s40164-023-00407-0. - DOI - PMC - PubMed